Devang Patel, MD
Pulmonary Disease · Stuart, FLNPI 1669546222
Payments from drug & device makers
Across 138 payments — averaging $47.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$1K
- AstraZeneca$1K
- Regeneron Healthcare Solutions, Inc.$639
- GSK$528
- Boehringer Ingelheim$445
- Mylan Specialty L.p.$265
- plus $3K from 24 others
What the payments were for
- Travel & lodging$76312%
- Food & beverage$5,82488%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 9 | $1,164 |
| AstraZeneca | 28 | $1,013 |
| Regeneron Healthcare Solutions, Inc. | 6 | $639 |
| GSK | 24 | $528 |
| Boehringer Ingelheim | 18 | $445 |
| Mylan Specialty L.p. | 13 | $265 |
| United Therapeutics Corporation | 3 | $263 |
| Insmed, Inc. | 2 | $238 |
| Genentech USA, Inc. | 2 | $210 |
| Sanofi | 2 | $143 |
| Sunovion Pharmaceuticals Inc. | 7 | $138 |
| Gilead | 1 | $125 |
| Seagen Inc. | 1 | $125 |
| Mirati Therapeutics, Inc. | 1 | $125 |
| Johnson & Johnson | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $125 |
| AMAG Pharmaceuticals, Inc. | 1 | $125 |
| Dova Pharmaceuticals | 1 | $125 |
| Boston Scientific | 1 | $114 |
| Amgen | 1 | $110 |
| Pulmonx Corporation | 1 | $105 |
| Mallinckrodt Enterprises LLC | 1 | $72 |
| Merck | 1 | $72 |
| Circassia Inc. | 3 | $50 |
| Advanced Respiratory, Inc | 2 | $44 |
| Resmed Corp | 2 | $38 |
| Grifols USA, LLC | 2 | $26 |
| Pfizer | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Philips North America LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,596 in reported general payments places this provider in the 55th percentile of 953 pulmonary disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Stuart
- James KrainsonMiami$11.7M
- Jose DiazLeesburg$11.2M
- Carlos MartinezHomestead$9.2M
- Leonard DunnDunedin$7.6M
- Francis AverillClearwater$6.3M
- Charles BurgerJacksonville$5.6M
- Daniel LorchBrandon$5.5M
- Lourdes BoschMiami$4.2M
- Raj KarunakaraOcala$4M
- Neal WarshoffLoxahatchee$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.